James Condulis
Stock Analyst at Stifel
(1.93)
# 3,160
Out of 5,127 analysts
9
Total ratings
37.5%
Success rate
9.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $44 → $50 | $35.00 | +42.86% | 2 | Dec 16, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $7.5 → $10 | $3.55 | +181.69% | 1 | Dec 5, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $24 | $13.48 | +78.04% | 1 | Sep 29, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $87 → $96 | $63.36 | +51.52% | 2 | Sep 2, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $40.88 | +164.19% | 2 | Mar 28, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $30.25 | -0.83% | 1 | Jan 22, 2025 |
NewAmsterdam Pharma Company
Dec 16, 2025
Maintains: Buy
Price Target: $44 → $50
Current: $35.00
Upside: +42.86%
X4 Pharmaceuticals
Dec 5, 2025
Maintains: Buy
Price Target: $7.5 → $10
Current: $3.55
Upside: +181.69%
Aardvark Therapeutics
Sep 29, 2025
Initiates: Buy
Price Target: $24
Current: $13.48
Upside: +78.04%
Cytokinetics
Sep 2, 2025
Maintains: Buy
Price Target: $87 → $96
Current: $63.36
Upside: +51.52%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $40.88
Upside: +164.19%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $30.25
Upside: -0.83%